Recommended Measures for the Assessment of Cognitive and Physical Performance in Older Patients with Dementia: a Systematic Review

Overview

Journal Dement Geriatr Cogn Dis Extra

Publisher Karger

Specialty Geriatrics

Date 2013 Jan 24

PMID 23341825

Citations 41

Authors

Willem J R Bossers

Lucas H V van der Woude

Froukje Boersma

Erik J A Scherder

Marieke J G van Heuvelen

Affiliations

Soon will be listed here.

Abstract

Unlabelled: AIM/GOAL: To recommend a set of neuropsychological and physical exercise tests for researchers to assess cognition and physical fitness in clinical trials with older patients with dementia; to create consensus, decrease heterogeneity, and improve research quality.

Methods: A literature search (2005-2011) yielded 89 randomized controlled trials. To provide information on test recommendations the frequency of test use, effect size of the test outcome, study quality, and psychometric properties of tests were analyzed.

Results: Fifty-nine neuropsychological tests (cognitive domains: global cognition, executive functioning, memory, and attention) and 10 exercise tests (physical domains: endurance capacity, muscle strength, balance, and mobility) were found.

Conclusion: The Severe Impairment Battery, Mini Mental State Examination, and Alzheimer Disease Assessment Scale - cognitive subscale were recommended to measure global cognition. The Verbal Fluency Test Category/Letters, Clock Drawing Test, and Trail Making Test-B were recommended to measure executive functioning. No specific memory test could be recommended. The Digit Span Forward, Digit Span Backward, and Trail Making Test-A were recommended to measure attention. As physical exercise tests, the Timed Up and Go and Six Meter Walk for mobility, the Six Minute Walk Distance for endurance capacity, and the Tinetti Balance Scale were recommended.

Citing Articles

Association between periodontal disease and age-related cognitive impairment: a narrative review.

Saji N, Matsushita K, Takeda A, Sakurai T BMC Oral Health. 2025; 25(1):373.

PMID: 40082811 PMC: 11907832. DOI: 10.1186/s12903-025-05632-z.

A Tablet-Based App to Support Nursing Home Staff in Delivering an Individualized Cognitive and Physical Exercise Program for Individuals With Dementia: Mixed Methods Usability Study.

Krafft J, Barisch-Fritz B, Krell-Roesch J, Trautwein S, Scharpf A, Woll A JMIR Aging. 2023; 6:e46480.

PMID: 37606974 PMC: 10481225. DOI: 10.2196/46480.

An Overview of Systemic Health Factors Related to Rapid Oral Health Deterioration among Older People.

van der Putten G, de Baat C J Clin Med. 2023; 12(13).

PMID: 37445340 PMC: 10342842. DOI: 10.3390/jcm12134306.

Protocol for a randomised, placebo-controlled, double-blinded clinical trial on the effect of oestrogen replacement on physical performance to muscle resistance exercise for older women with osteoarthritis of knee joint: the EPOK trial.

Mitoma T, Maki J, Ooba H, Eto E, Takahashi K, Kondo T BMC Geriatr. 2023; 23(1):104.

PMID: 36800940 PMC: 9938988. DOI: 10.1186/s12877-023-03828-y.

Latest Trends in Outcome Measures in Dementia and Mild Cognitive Impairment Trials.

Garg D, Gupta A, Agarwal A, Mishra B, Srivastava M, Basheer A Brain Sci. 2022; 12(7).

PMID: 35884729 PMC: 9313078. DOI: 10.3390/brainsci12070922.

References

Levin O, Batukaeva L, Smolentseva I, Amosova N . Efficacy and safety of memantine in Lewy body dementia. Neurosci Behav Physiol. 2009; 39(6):597-604. DOI: 10.1007/s11055-009-9167-x. View

Tombaugh T, McIntyre N . The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992; 40(9):922-35. DOI: 10.1111/j.1532-5415.1992.tb01992.x. View

Onder G, Zanetti O, Giacobini E, Frisoni G, Bartorelli L, Carbone G . Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial. Br J Psychiatry. 2005; 187:450-5. DOI: 10.1192/bjp.187.5.450. View

Raggi A, Iannaccone S, Marcone A, Ginex V, Ortelli P, Nonis A . The effects of a comprehensive rehabilitation program of Alzheimer's Disease in a hospital setting. Behav Neurol. 2007; 18(1):1-6. PMC: 5469961. DOI: 10.1155/2007/782959. View

Mohs R . The Alzheimer's Disease Assessment Scale. Int Psychogeriatr. 1996; 8(2):195-203. DOI: 10.1017/s1041610296002578. View

Frankfort S, Appels B, de Boer A, Tulner L, Van Campen J, Koks C . Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Pharmacoepidemiol Drug Saf. 2006; 16(5):545-51. DOI: 10.1002/pds.1345. View

Chiu Y, Li C, Lin K, Chiu Y, Liu H . Sensitivity and specificity of the Clock Drawing Test, incorporating Rouleau scoring system, as a screening instrument for questionable and mild dementia: scale development. Int J Nurs Stud. 2006; 45(1):75-84. DOI: 10.1016/j.ijnurstu.2006.09.005. View

Hampel H, Ewers M, Burger K, Annas P, Mortberg A, Bogstedt A . Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry. 2009; 70(6):922-31. View

Schmitt F, Ashford W, Ernesto C, Saxton J, Schneider L, Clark C . The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S51-6. View

10.

Mizukami K, Asada T, Kinoshita T, Tanaka K, Sonohara K, Nakai R . A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol. 2008; 12(2):191-9. DOI: 10.1017/S146114570800970X. View

11.

Albert M, Cohen C . The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc. 1992; 40(5):449-53. DOI: 10.1111/j.1532-5415.1992.tb02009.x. View

12.

Kwok T, Lee J, Lam L, Woo J . Vitamin B(12) supplementation did not improve cognition but reduced delirium in demented patients with vitamin B(12) deficiency. Arch Gerontol Geriatr. 2007; 46(3):273-82. DOI: 10.1016/j.archger.2007.05.001. View

13.

Boxer A, Lipton A, Womack K, Merrilees J, Neuhaus J, Pavlic D . An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord. 2009; 23(3):211-7. PMC: 2760056. DOI: 10.1097/WAD.0b013e318197852f. View

14.

Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M . Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010; 9(7):702-16. DOI: 10.1016/S1474-4422(10)70119-8. View

15.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

16.

Schmitt F, Saxton J, Xu Y, McRae T, Sun Y, Richardson S . A brief instrument to assess treatment response in the patient with advanced Alzheimer disease. Alzheimer Dis Assoc Disord. 2009; 23(4):377-83. DOI: 10.1097/WAD.0b013e3181ac9cc1. View

17.

Auchus A, Brashear H, Salloway S, Korczyn A, De Deyn P, Gassmann-Mayer C . Galantamine treatment of vascular dementia: a randomized trial. Neurology. 2007; 69(5):448-58. DOI: 10.1212/01.wnl.0000266625.31615.f6. View

18.

Weyer G, Erzigkeit H, Kanowski S, Ihl R, Hadler D . Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int Psychogeriatr. 1997; 9(2):123-38. DOI: 10.1017/s1041610297004298. View

19.

Clark C, Forman M . Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum. Arch Neurol. 2006; 63(4):489-90. DOI: 10.1001/archneur.63.4.489. View

20.

Ahn I, Kim J, Ku H, Saxton J, Kim D . Reliability and validity of the severe impairment battery (SIB) in Korean dementia patients. J Korean Med Sci. 2006; 21(3):506-17. PMC: 2729960. DOI: 10.3346/jkms.2006.21.3.506. View